前列腺癌
Carcinoma of the prostate.
作者信息
Orovan W L, Demaria J E
出版信息
Can Fam Physician. 1985 Jun;31:1271-5.
Abstract
Prostatic carcinoma is the third most common cause of death from cancer among males. Selection of appropriate therapy and evaluation of results is often difficult, since patients present at different stages of the disease. Methods of staging, diagnosis, treatment of localized tumor, radiation, surgery and treatment of metastases are described.
摘要
前列腺癌是男性癌症死亡的第三大常见原因。由于患者处于疾病的不同阶段，选择合适的治疗方法并评估结果往往很困难。本文描述了分期、诊断、局限性肿瘤的治疗、放疗、手术及转移灶治疗的方法。
相似文献
1
Carcinoma of the prostate.前列腺癌
Can Fam Physician. 1985 Jun;31:1271-5.
2
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
3
Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.
Cancer. 1993 Dec 1;72(11):3156-73. doi: 10.1002/1097-0142(19931201)72:11<3156::aid-cncr2820721106>3.0.co;2-g.
4
5
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer.局部肿瘤控制对前列腺癌外照射放疗后远处转移及癌症相关死亡率的影响。
J Urol. 2008 Apr;179(4):1368-73; discussion 1373. doi: 10.1016/j.juro.2007.11.063. Epub 2008 Mar 4.
6
7
Positron emission tomography for prostate, bladder, and renal cancer.用于前列腺癌、膀胱癌和肾癌的正电子发射断层扫描。
Semin Nucl Med. 2004 Oct;34(4):274-92. doi: 10.1053/j.semnuclmed.2004.06.004.
8
Calculated prostate carcinoma volume: The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter.计算得出的前列腺癌体积：术前前列腺特异性抗原（PSA）水平为4-20纳克/毫升的患者接受手术或放射治疗后3年无PSA失败生存的最佳预测指标。
Cancer. 1998 Jan 15;82(2):334-41. doi: 10.1002/(sici)1097-0142(19980115)82:2<342::aid-cncr14>3.0.co;2-z.
9
Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.局限性前列腺癌盆腔淋巴结照射的非随机评估
Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):573-84. doi: 10.1016/s0360-3016(96)00378-1.
10
Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.加拿大前列腺癌手术医院资金改革后管理策略和患者选择
JAMA Netw Open. 2019 Aug 2;2(8):e1910505. doi: 10.1001/jamanetworkopen.2019.10505.
本文引用的文献
1
Impotence following radical prostatectomy: insight into etiology and prevention.根治性前列腺切除术后的阳痿：病因及预防探究
J Urol. 1982 Sep;128(3):492-7. doi: 10.1016/s0022-5347(17)53012-8.
2
Radical surgery versus radiotherapy for adenocarcinoma of the prostate.
J Urol. 1982 Sep;128(3):502-4. doi: 10.1016/s0022-5347(17)53016-5.
3
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.前列腺癌治疗的新方法：完全而非部分去除雄激素。
Prostate. 1983;4(6):579-94. doi: 10.1002/pros.2990040605.
4
Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer?通过放射免疫测定法测定前列腺酸性磷酸酶会提高早期前列腺癌的诊断率吗？
J Urol. 1981 Mar;125(3):361-4. doi: 10.1016/s0022-5347(17)55037-5.
5
On the incidence of carcinoma of the prostate.关于前列腺癌的发病率。
J Pathol Bacteriol. 1965 Jul;90(1):217-24. doi: 10.1002/path.1700900123.
6
Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment.
J Urol. 1972 Dec;108(6):908-13. doi: 10.1016/s0022-5347(17)60904-2.
7
Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.前列腺癌：208例根治性前列腺切除术某些病理特征的预后评估。采用连续切片技术进行检查。
Cancer. 1972 Jul;30(1):5-13. doi: 10.1002/1097-0142(197207)30:1<5::aid-cncr2820300103>3.0.co;2-s.
8
Proceedings: The natural history of prostatic cancer.会议论文集：前列腺癌的自然病史
Cancer. 1973 Nov;32(5):1104-12. doi: 10.1002/1097-0142(197311)32:5<1104::aid-cncr2820320515>3.0.co;2-t.
9
The Veterans' Administration Cooperative Urological Research Group studies of carcinoma of the prostate: a review.退伍军人管理局合作泌尿外科研究组关于前列腺癌的研究：综述
Cancer Chemother Rep. 1975 Jan-Feb;59(1):225-7.
10
Probabilities of eventually developing and of dying of cancer (risk among persons previously undiagnosed with the cancer).
CA Cancer J Clin. 1978 Jan-Feb;28(1):33-46. doi: 10.3322/canjclin.28.1.33.
Zotero 插件